DI-UMONS : Dépôt institutionnel de l’université de Mons

Recherche transversale
(titres de publication, de périodique et noms de colloque inclus)
2008-01-01 - Article/Dans un journal avec peer-review - Anglais - 11 page(s) (Soumise)

Larbanoix Lionel, Burtea Carmen , Laurent Sophie , Van Leuven Fred, Toubeau Gérard, Vander Elst Luce , Muller Robert , "Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease" in Neurobiology of Aging, 31, 10, 1679-1689

  • Edition : Elsevier, New York (NY)
  • Codes CREF : Histologie (DI3212), Sciences biomédicales (DI3200), Biologie moléculaire (DI3111), Neuropathologie (DI332C), Pharmacocinétique (DI3431), Chimie organique (DI1313), Imagerie médicale, radiologie, tomographie (DI3243)
  • Unités de recherche UMONS : Chimie générale, organique et biomédicale (M108), Histologie (M118)
Texte intégral :

Abstract(s) :

(Anglais) Amyloid plaques (AP) represent one of the main molecular hallmarks of Alzheimer's disease (AD). In order to develop new AP-specific contrast agents for AD molecular imaging, the phage display technology was used to identify peptides specific to amyloid-beta (Aß42). A random disulfide constrained heptapeptide phage display library was screened against Aß42. After biopanning, 72 phage clones were isolated and their binding affinity to Aß42 was evaluated by enzyme-linked immunosorbent assay (ELISA). The final library was enriched in two peptide sequences. The Kd of candidate phage clones for binding to Aß42 are in the picomolar range. The binding affinity for Aß42 of two selected peptides was confirmed by ELISA, and the specific interaction with AP was validated by immunohistochemistry on brain sections. The preliminary MRI in vivo study, which was performed with a peptide functionalized contrast agent on AD transgenic mouse, showed encouraging results. To conclude, low molecular weight peptides presenting a specific affinity for Aß42 were identified by phage display. As specific carriers, they have a real potential for molecular imaging of AD thanks to AP binding.

Identifiants :
  • PMID : 19027991
  • DOI : 10.1016/j.neurobiolaging.2008.09.021

Mots-clés :
  • (Anglais) peptides
  • (Anglais) Phage display
  • (Anglais) Amyloid plaques
  • (Anglais) MRI contrast agents
  • (Anglais) molecular imaging
  • (Anglais) functionalized iron oxide nanoparticles
  • (Anglais) Alzheimer’s disease
  • (Anglais) Amyloid-beta